Skip to main content
65°
Clear
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Telesis Bio, Inc. - Common Stock
(NQ:
TBIO
)
3.440
-0.260 (-7.03%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Telesis Bio, Inc. - Common Stock
Telesis Bio Reports Second Quarter and First Half 2024 Financial Results
August 07, 2024
From
Telesis Bio
Via
GlobeNewswire
Telesis Bio Reports First Quarter 2024 Financial Results
May 09, 2024
From
Telesis Bio
Via
GlobeNewswire
Telesis Bio Announces Reverse Stock Split
May 06, 2024
From
Telesis Bio
Via
GlobeNewswire
Telesis Bio Inc. announces strategic focus on game-changing Gibson SOLA enzymatic DNA synthesis (EDS) platform and BioXp mRNA solutions and announces new leadership
April 18, 2024
From
Telesis Bio
Via
GlobeNewswire
Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial Results
March 28, 2024
From
Telesis Bio
Via
GlobeNewswire
Stocks Making Waves: Insights into Key Developments and Potential VTAK, TBIO, OCEA, ONMD, KZIA
February 26, 2024
Via
AB Newswire
Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial Results
February 26, 2024
Telesis Bio announces Q4 and full-year 2023 select preliminary financial results, highlighting strong BioXp kit sales, expanding gross margin and reduced expense
From
Telesis Bio
Via
GlobeNewswire
Telesis Bio Reports Third Quarter 2023 Financial Results
November 13, 2023
From
Telesis Bio
Via
GlobeNewswire
Telesis Bio to Report Third Quarter Financial Results on Monday, November 13, 2023
November 07, 2023
From
Telesis Bio
Via
GlobeNewswire
Telesis Bio Announces Commercial Release of Cell-free Amplification Kit for Generation of Transfection-scale DNA
November 03, 2023
New Kit offers BioXp automation workflow from candidate sequence to amplified DNA in days
From
Telesis Bio
Via
GlobeNewswire
Telesis Bio Announces Commercial Release of BioXp® NGS Library Prep Kit for WGS
September 28, 2023
New Kit expands suite of NGS Library Prep solutions on the BioXp® System Enabling Speed and Efficiency for Whole genome sequencing (WGS) applications with the Automated Molecular Biology Workstation
From
Telesis Bio
Via
GlobeNewswire
Telesis Bio Appoints William J. Kullback Chief Financial Officer
August 29, 2023
From
Telesis Bio
Via
GlobeNewswire
Telesis Bio Reports Second Quarter 2023 Financial Results
August 10, 2023
-- Total revenue of $8.7M in 2QFY23 - increased by 53% year over year
From
Telesis Bio
Via
GlobeNewswire
Telesis Bio to Report Second Quarter Financial Results on Thursday, August 10, 2023
August 03, 2023
From
Telesis Bio
Via
GlobeNewswire
Telesis Bio to Present at Jefferies Healthcare Conference 2023
June 08, 2023
From
Telesis Bio
Via
GlobeNewswire
Telesis Bio to Present at Antibody Engineering and Therapeutics, Europe 2023
June 06, 2023
Showcasing full suite of molecular biology workflow solutions for streamlining antibody discovery
From
Telesis Bio
Via
GlobeNewswire
Telesis Bio Announces Closing of $28.0 Million Private Placement of Preferred Stock And Warrants to Purchase an Additional $46.2 Million of Common Stock
June 05, 2023
From
Telesis Bio
Via
GlobeNewswire
Telesis Bio Secures Financing of $28.0 Million
May 31, 2023
From
Telesis Bio
Via
GlobeNewswire
Telesis Bio to Present at SynBioBeta 2023
May 23, 2023
Highlighting application of the Molecular Biology Workstation to accelerating vaccine and biologics discovery
From
Telesis Bio
Via
GlobeNewswire
Telesis Bio Announces First Commercial Shipment of BioXp® Select DNA Cloning Kit
May 22, 2023
New Kit Enables Automation of DNA Cloning on the BioXp® System Beginning from Linear DNA, Further Expanding the Utility, Speed, and Impact of the BioXp® Automated Molecular Biology Workstation
From
Telesis Bio
Via
GlobeNewswire
Telesis Bio Announces First Commercial Shipment of BioXp® NGS Library Prep Kit
May 18, 2023
New Kit Enables Automation of NGS Library Prep on the BioXp® System Further Expanding the Utility, Speed, and Impact of the BioXp® Automated Molecular Biology Workstation
From
Telesis Bio
Via
GlobeNewswire
Telesis Bio to Present at Protein Engineering Summit (PEGS Boston 2023)
May 15, 2023
Showcasing Automated Molecular Biology Workstation for Synthetic Biology and Genomics Applications
From
Telesis Bio
Via
GlobeNewswire
Telesis Bio Reports First Quarter 2023 Financial Results
May 11, 2023
From
Telesis Bio
Via
GlobeNewswire
Telesis Bio to Report First Quarter Financial Results on Thursday, May 11, 2023
April 27, 2023
From
Telesis Bio
Via
GlobeNewswire
Telesis Bio Releases BioXp® Select Kits to Enable DNA Amplification and Scale-up
March 31, 2023
New Releases Extend the BioXp® Select Product Line, Further Expanding the Utility, Speed, and Impact of the BioXp® Automated Synthetic Biology Workstation
From
Telesis Bio
Via
GlobeNewswire
Telesis Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Guidance
March 21, 2023
From
Telesis Bio
Via
GlobeNewswire
Telesis Bio to Present at Festival of Biologics Conference
March 16, 2023
Daniel Gibson, Ph.D., CTO and Co-founder to Present “Building Biology Overnight: Eliminating Synthesis Bottlenecks with Hands-free Automated Synthetic Biology Solutions”
From
Telesis Bio
Via
GlobeNewswire
Telesis Bio to Report Fourth Quarter and Full Year 2022 Financial Results on Tuesday, March 21, 2023
March 09, 2023
From
Telesis Bio
Via
GlobeNewswire
Telesis Bio to Present at the Cowen 43rd Annual Healthcare Conference
February 27, 2023
From
Telesis Bio
Via
GlobeNewswire
Telesis Bio Releases BioXp® Select mRNA Synthesis Kit to Expand the Utility, Speed, and Impact of Its Automated Synthetic Biology Workstation
February 16, 2023
Scientists Can Now Begin the mRNA Synthesis Process from Their Own Sequence or Plasmid DNA
From
Telesis Bio
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.